Press Releases Viva Biotech Holdings

Equities

1873

KYG9390W1015

Market Closed - Hong Kong S.E. Other stock markets 01:38:35 13/05/2024 pm IST			5-day change	1st Jan Change
0.6 ^HKD	+1.69%		-3.23%	-42.86%

28/03	Viva Biotech Holdings Reports Earnings Results for the Full Year Ended December 31, 2023	CI
18/01	Viva Biotech Holdings Appoints WANG Stephen Hui as Non-Executive Director	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future	28/03	PR
Viva Biotech Announces 2023 Interim Results Solid Growth in Main Business, Significant Rebound in Profitability	30/23/30	AQ
Viva Biotech (1873.HK) Announces 2023 Interim Results: Solid Growth in Main Business, Significant Rebound in Profitability	29/23/29	PR
Latest Updates of 7 Viva's Portfolio Companies	28/23/28	PR
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs	20/23/20	PR
HONOR Partners with AIGC Artist to Share the Vibe of Upcoming HONOR 90	19/23/19	AQ
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million	16/23/16	PR
Viva Biotech Successfully Held The 3rd Annual Partnership Summit	23/22/23	PR
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7%	28/22/28	PR
Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests	18/22/18	PR
Viva Biotech : Announced 2021 Interim Results	30/21/30	PR
Viva Biotech : PROPOSED RE-ELECTION OF RETIRING DIRECTORS PROPOSED RE-APPOINTMENT OF AUDITOR PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND AND NOTICE OF ANNUAL GENERAL MEETING	28/21/28	PU
Viva Biotech : CHANGE OF CHIEF FINANCIAL OFFICER	26/21/26	PU
Viva Biotech : Announced 2020 Annual Results	31/21/31	PR
Viva Biotech : SUPPLEMENTAL ANNOUNCEMENT REGARDING THE ANNOUNCEMENT PUBLISHED ON MARCH 16, 2021	19/21/19	PU
Viva Biotech : (Re-published for debt holders information) PROFIT WARNING	17/21/17	PU
Viva Biotech : COMPLETION OF THE ACQUISITION OF THE ENTIRE EQUITY INTEREST IN SYNTHESIS MED CHEM (HONG KONG) LIMITED INVOLVING ISSUE OF CONSIDERATION SHARES UNDER GENERAL MANDATE	05/21/05	PU
Viva Biotech : MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF THE ENTIRE ISSUED SHARE CAPITAL IN SYNTHESIS MED CHEM (HONG KONG) LIMITED	25/21/25	PU
Viva Biotech : PROPOSED INCREASE OF AUTHORIZED SHARE CAPITAL	23/20/23	PU
Viva Biotech : DISCLOSEABLE TRANSACTION-ENTRY INTO THE INVESTMENT AGREEMENT WITH HANGZHOU QIANTANG NEW AREA MANAGEMENT COMMITTEE	22/20/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Viva Biotech Holdings

Equities

1873

KYG9390W1015

Press Releases

Filters